FDA Flags Minor CMC Changes That Only Require an Annual Report

Drug Industry Daily
A A
Biologics sponsors will only need to report minor postapproval manufacturing changes on an annual basis, said the FDA in a new draft guidance.

To View This Article:

Login

Subscribe To Drug Industry Daily